...
首页> 外文期刊>International Journal of Experimental Diabetes Research: Experimental Diabesity Research >Angiotensin II Type II Receptor Deficiency Accelerates the Development of Nephropathy in Type I Diabetes via Oxidative Stress and ACE2
【24h】

Angiotensin II Type II Receptor Deficiency Accelerates the Development of Nephropathy in Type I Diabetes via Oxidative Stress and ACE2

机译:血管紧张素II型II型受体缺乏症通过氧化应激和ACE2促进I型糖尿病肾病的发展

获取原文
           

摘要

Since the functional role(s) of angiotensin II (Ang II) type II receptor (AT2R) in type I diabetes is unknown, we hypothesized that AT2R is involved in decreasing the effects of type I diabetes on the kidneys. We induced diabetes with low-dose streptozotocin (STZ) in both AT2R knockout (AT2RKO) and wild-type (WT) male mice aged 12 weeks and followed them for 4 weeks. Three subgroups nondiabetic, diabetic, and insulin-treated diabetic (Rx insulin implant) were studied. Systolic blood pressure (SBP), physiological parameters, glomerular filtration rate (GFR), renal morphology, gene expression, and apoptosis were assessed. After 4 weeks of diabetes, compared to WT controls, AT2RKO mice clearly developed features of early diabetic nephropathy (DN), such as renal hypertrophy, tubular apoptosis, and progressive extracellular matrix (ECM) protein accumulation as well as increased GFR. AT2RKO mice presented hypertension unaffected by diabetes. Renal oxidative stress (measured as heme oxygenase 1 (HO-1) gene expression and reactive oxygen species (ROS) generation) and intrarenal renin angiotensin system components, such as angiotensinogen (Agt), AT1R, and angiotensin-converting enzyme (ACE) gene expression, were augmented whereas angiotensin-converting enzyme2 (ACE2) gene expression was decreased in renal proximal tubules (RPTs) of AT2RKO mice. The renal changes noted above were significantly enhanced in diabetic AT2RKO mice but partially attenuated in insulin-treated diabetic WT and AT2RKO mice. In conclusion, AT2R deficiency accelerates the development of DN, which appears to be mediated, at least in part, via heightened oxidative stress and ACE/ACE2 ratio in RPTs.
机译:由于尚不知道血管紧张素II(Ang II)II型受体(AT2R)在I型糖尿病中的功能作用,因此我们假设AT2R参与了降低I型糖尿病对肾脏的影响。我们在12周龄的AT2R基因敲除(AT2RKO)和野生型(WT)雄性小鼠中均使用低剂量链脲佐菌素(STZ)诱导了糖尿病,并对其进行了4周的随访。研究了三个非糖尿病,糖尿病和接受胰岛素治疗的糖尿病(Rx胰岛素植入物)亚组。评估了收缩压(SBP),生理参数,肾小球滤过率(GFR),肾脏形态,基因表达和细胞凋亡。与野生型对照组相比,糖尿病4周后,AT2RKO小鼠明显发展出早期糖尿病肾病(DN)的特征,例如肾肥大,肾小管凋亡和进行性细胞外基质(ECM)蛋白积累以及GFR增加。 AT2RKO小鼠表现出不受糖尿病影响的高血压。肾氧化应激(以血红素加氧酶1(HO-1)基因表达和活性氧(ROS)生成来衡量)和肾内肾素血管紧张素系统成分,例如血管紧张素原(Agt),AT1R和血管紧张素转化酶(ACE)基因在AT2RKO小鼠的肾近端小管(RPT)中,血管紧张素转化酶2(ACE2)基因表达降低,而血管紧张素转换酶2(ACE2)基因表达降低。上面提到的肾脏变化在糖尿病AT2RKO小鼠中明显增强,但在胰岛素治疗的糖尿病WT和AT2RKO小鼠中部分减弱。总之,AT2R缺乏会加速DN的发展,这似乎至少部分是通过RPT中氧化应激和ACE / ACE2比的升高来介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号